1. Home
  2. JVA vs COCP Comparison

JVA vs COCP Comparison

Compare JVA & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$4.47

Market Cap

17.8M

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.40

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
COCP
Founded
1971
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.8M
15.6M
IPO Year
1997
2011

Fundamental Metrics

Financial Performance
Metric
JVA
COCP
Price
$4.47
$1.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
232.1K
4.5M
Earning Date
03-16-2026
05-14-2026
Dividend Yield
1.81%
N/A
EPS Growth
N/A
54.65
EPS
0.29
N/A
Revenue
$90,655,294.00
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.24
N/A
Revenue Growth
17.54
N/A
52 Week Low
$2.93
$0.86
52 Week High
$5.62
$2.19

Technical Indicators

Market Signals
Indicator
JVA
COCP
Relative Strength Index (RSI) 66.12 61.76
Support Level $4.02 $0.95
Resistance Level $4.78 $1.42
Average True Range (ATR) 0.24 0.15
MACD -0.01 0.02
Stochastic Oscillator 72.73 38.84

Price Performance

Historical Comparison
JVA
COCP

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: